Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:alsoKnownAs |
gptkb:RG7388
gptkb:RO5503781 |
| gptkbp:CASNumber |
gptkb:1229705-06-9
|
| gptkbp:chemicalClass |
spiro-oxindole derivative
|
| gptkbp:clinicalTrialPhase |
gptkb:Phase_I
Phase II |
| gptkbp:developedBy |
gptkb:Roche
|
| gptkbp:hasMolecularFormula |
C31H29Cl2N3O4
|
| https://www.w3.org/2000/01/rdf-schema#label |
idasanutlin
|
| gptkbp:intendedUse |
anticancer agent
|
| gptkbp:investigatedBy |
gptkb:acute_myeloid_leukemia
solid tumors |
| gptkbp:mechanismOfAction |
MDM2 inhibitor
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL3544943
46224522 |
| gptkbp:restored |
p53 tumor suppressor function
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
gptkb:anemia
nausea diarrhea fatigue thrombocytopenia |
| gptkbp:status |
investigational drug
|
| gptkbp:target |
gptkb:MDM2_protein
|
| gptkbp:UNII |
6Q1K1QF0X1
|
| gptkbp:bfsParent |
gptkb:MDM2
|
| gptkbp:bfsLayer |
6
|